vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
OCEANEERING INTERNATIONAL INC is the larger business by last-quarter revenue ($692.4M vs $397.6M, roughly 1.7× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs 5.2%, a 0.0% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
GRDN vs OII — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $692.4M |
| Net Profit | $20.9M | $36.1M |
| Gross Margin | 21.5% | — |
| Operating Margin | 7.7% | — |
| Net Margin | 5.3% | 5.2% |
| Revenue YoY | — | 3.6% |
| Net Profit YoY | — | -28.3% |
| EPS (diluted) | — | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $692.4M | ||
| Q4 25 | $397.6M | $668.6M | ||
| Q3 25 | $377.4M | $742.9M | ||
| Q2 25 | $344.3M | $698.2M | ||
| Q1 25 | $329.3M | $674.5M | ||
| Q4 24 | — | $713.5M | ||
| Q3 24 | $314.4M | $679.8M | ||
| Q2 24 | — | $668.8M |
| Q1 26 | — | $36.1M | ||
| Q4 25 | $20.9M | $177.7M | ||
| Q3 25 | $9.8M | $71.3M | ||
| Q2 25 | $9.0M | $54.4M | ||
| Q1 25 | $9.4M | $50.4M | ||
| Q4 24 | — | $56.1M | ||
| Q3 24 | $-122.0M | $41.2M | ||
| Q2 24 | — | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | 21.5% | 19.8% | ||
| Q3 25 | 19.8% | 20.6% | ||
| Q2 25 | 19.8% | 21.3% | ||
| Q1 25 | 19.5% | 20.0% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | 19.4% | 19.3% | ||
| Q2 24 | — | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 9.8% | ||
| Q3 25 | 4.3% | 11.6% | ||
| Q2 25 | 3.7% | 11.3% | ||
| Q1 25 | 3.9% | 10.9% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | -33.3% | 10.5% | ||
| Q2 24 | — | 9.0% |
| Q1 26 | — | 5.2% | ||
| Q4 25 | 5.3% | 26.6% | ||
| Q3 25 | 2.6% | 9.6% | ||
| Q2 25 | 2.6% | 7.8% | ||
| Q1 25 | 2.9% | 7.5% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | -38.8% | 6.1% | ||
| Q2 24 | — | 5.2% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | — | $1.75 | ||
| Q3 25 | — | $0.71 | ||
| Q2 25 | — | $0.54 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.55 | ||
| Q3 24 | — | $0.40 | ||
| Q2 24 | — | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | — |
| Total DebtLower is stronger | $0 | $488.8M |
| Stockholders' EquityBook value | $217.9M | $1.1B |
| Total Assets | $412.7M | $2.6B |
| Debt / EquityLower = less leverage | 0.00× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $65.6M | $695.9M | ||
| Q3 25 | $36.5M | $7.0M | ||
| Q2 25 | $18.8M | $7.0M | ||
| Q1 25 | $14.0M | $7.0M | ||
| Q4 24 | — | $504.5M | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $488.8M | ||
| Q4 25 | $0 | $487.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $482.0M | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $217.9M | $1.1B | ||
| Q3 25 | $195.5M | $907.7M | ||
| Q2 25 | $179.7M | $842.1M | ||
| Q1 25 | $163.2M | $773.1M | ||
| Q4 24 | — | $714.3M | ||
| Q3 24 | $133.9M | $698.0M | ||
| Q2 24 | — | $651.0M |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $412.7M | $2.7B | ||
| Q3 25 | $390.0M | $2.5B | ||
| Q2 25 | $356.3M | $2.3B | ||
| Q1 25 | $334.0M | $2.3B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | $348.0M | $2.4B | ||
| Q2 24 | — | $2.3B |
| Q1 26 | — | 0.44× | ||
| Q4 25 | 0.00× | 0.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | — |
| Free Cash FlowOCF − Capex | — | $-76.5M |
| FCF MarginFCF / Revenue | — | -11.1% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $34.6M | $221.1M | ||
| Q3 25 | $28.2M | $101.3M | ||
| Q2 25 | $19.9M | $77.2M | ||
| Q1 25 | $17.6M | $-80.7M | ||
| Q4 24 | — | $128.4M | ||
| Q3 24 | — | $91.9M | ||
| Q2 24 | — | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | — | $190.7M | ||
| Q3 25 | $24.2M | $77.0M | ||
| Q2 25 | — | $46.9M | ||
| Q1 25 | — | $-106.8M | ||
| Q4 24 | — | $94.5M | ||
| Q3 24 | — | $67.0M | ||
| Q2 24 | — | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | — | 28.5% | ||
| Q3 25 | 6.4% | 10.4% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | -15.8% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | — | 4.6% | ||
| Q3 25 | 1.1% | 3.3% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.65× | 1.24× | ||
| Q3 25 | 2.87× | 1.42× | ||
| Q2 25 | 2.21× | 1.42× | ||
| Q1 25 | 1.86× | -1.60× | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | — | 2.23× | ||
| Q2 24 | — | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
